Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia
Author(s) -
Tahaniyat Lalani,
Helen W. Boucher,
Sara E. Cosgrove,
Vance G. Fowler,
Zeina A. Kanafani,
Gloria Vigliani,
M. Campion,
Elías Abrutyn,
Donald P. Levine,
Connie Price,
Susan J. Rehm,
G. Ralph Corey,
Adolf W. Karchmer
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm437
Subject(s) - daptomycin , staphylococcus aureus , medicine , bacteremia , staphylococcal infections , microbiology and biotechnology , antibiotics , vancomycin , biology , bacteria , genetics
To evaluate the clinical characteristics, treatment and outcomes of patients with osteoarticular infections (OAIs) associated with Staphylococcus aureus bacteraemia (SAB).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom